Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations
Value in Health, 11/11/09
Hay JW et al. – Drug transaction prices not only ration current use of medication but also ration future biomedical research and development. CEA researchers should tailor the appropriate measure of drug costs to the analytic perspective, maintain clarity and transparency on drug cost measurement, and report the sensitivity of CEA results to reasonable drug cost measurement alternatives.
Related Articles
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report-Part III
Value in Health, 10/29/09
Relevance Score: 71%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective: The ISPOR Drug Cost Task Force Report-Part VI
Value in Health, 10/29/09
Relevance Score: 71%
Value-Based Insurance Design in Medicare
Applied Health Economics and Health Policy, 10/20/09
Relevance Score: 70%
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report-Part V
Value in Health, 10/29/09
Relevance Score: 69%
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and Other US Government Payers Perspectives: The ISPOR Drug Cost Task Force Report-Part IV
Value in Health, 10/19/09
Relevance Score: 69%
Today in Financial Management...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospitals seek opportunities from comparative effectiveness research
American Hospital Association News, 03/19/10
By setting too high a bar, EHR rules would hinder IT adoption, says AHA
American Hospital Association News, 03/19/10
Senate considers hospital issues in new jobs bill
American Hospital Association News, 03/19/10
Today in Health Policy/Research...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospitals seek opportunities from comparative effectiveness research
American Hospital Association News, 03/19/10
Small hospitals nursing peer review helps staff embrace culture of safety
American Hospital Association News, 03/19/10
Location technology used to boost ED patient flow
Canadian Healthcare Technology, 03/19/10
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
Journal of Clinical Pharmacy and Therapeutics, 03/19/10
Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
PharmacoEconomics, 03/16/10
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
European Journal of Clinical Pharmacology, 03/16/10
Article Search
Sponsor
Sponsor


See Latest Articles


